Company: STAA
Filing Date: 2025-10-17
Form Type: DFAN14A
Source: 0001213900-25-100009
Chunk: 2

Company: STAAR SURGICAL CO
Filing Date: 2025-10-17
Form: DFAN14A
Chunk 2
---
ine.com.

The text of the letter to the Board is as follows:

October 17, 2025

STAAR Surgical Company
25510 Commercentre Dr.
Lake Forest, CA 92630

Dear Members of the Board:

With incomplete information and after a poorly designed process, you decided
to sell STAAR to Alcon for a woefully inadequate price.

We have told you we disagree with that decision. So too have other large
institutional investors and all three proxy advisors. And now, it is time for all shareholders to express their views on this proposed
deal.

You have had months to justify your decision and solicit shareholder support
for the transaction. You have filed proxy statements, mailed letters to shareholders, issued press releases, released an investor presentation,
made hundreds of phone calls, and attended dozens of meetings with shareholders. There has been sufficient time and opportunity to tell
your story, and you have done so in accordance with the schedule you selected.

Now, it is time to allow the shareholders to speak.

The vote on this ill-advised transaction is scheduled for October 23, 2025.
We encourage you to allow the shareholders to decide whether they want to sell the Company on the terms you have negotiated.

We urge you to avoid the temptation to tilt the playing field by delaying
the meeting, releasing misleading statements, or otherwise attempting to cajole STAAR shareholders to agree to this misbegotten deal.

Your role, after all, is not that of a partisan advocate. Instead, as our
fiduciaries, your obligation is to objectively inform shareholders and allow us to decide what we want to do with our Company. You should
hold the vote without further delay or drama.

Once shareholders vote next week, we expect you to accept the result. If
shareholders reject the deal, we trust you will have the humility to recognize that the Board needs to work with shareholders to ensure
a better path forward. Between now and then, you should take no further substantive or diversionary actions. As we monitor the votes,
it is clear to us – and surely to you also – that shareholders lack confidence in this Board.

It is time for all shareholders to speak. And time for this Board to listen.

Sincerely,

Neal Bradsher

Founder and President

Broadwood Capital, Inc., General Partner of Broadwood Partners, L.P.

About Broadwood

Broadwood Partners, L.P. is managed by Broadwood Capital, Inc. Broadwood
Capital is a private investment firm based in